Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.
about
Retinoid roles in blocking hepatocellular carcinomaThe emerging roles of GPRC5A in diseasesPrognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospectsPeretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitro.Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.Retinoid X receptor ligands: a patent review (2007 - 2013).Analysis of temporal expression profiles after sciatic nerve injury by bioinformatic method.Polyunsaturated Branched-Chain Fatty Acid Geranylgeranoic Acid Induces Unfolded Protein Response in Human Hepatoma CellsPeretinoin as an adjuvant therapy for hepatocellular carcinoma.GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet.Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
P2860
Q26796665-443496E7-0040-46F8-BB07-B028731EFFFDQ27020926-34D4DF69-996E-4675-9B22-90B2B46E0372Q27021265-0D256EA3-B2F7-4162-8C63-12B3241A937BQ35055436-CD83544A-D941-4F5A-8D47-E5241510363EQ35698198-DDE2D19E-7322-4AB0-A213-3350FB7BD1AEQ37702746-CAB55559-986F-4397-AABD-893574B0A78FQ38165918-CFA141AA-34A6-4D2E-A6D2-1DBFED9E563AQ38181177-71E9ADC5-88D9-49E4-8FF3-9C6853B3587AQ38429221-1FEA1CB6-DC50-49E0-A5C4-540AF0F9DA00Q38851817-DBD6458B-7EF7-4DBF-BBA4-73846DD85FF3Q38959682-FEEFFB5C-8CA9-4FB3-875B-A10CE8FAA434Q39602604-127D56E7-0A22-41CD-BC28-073E99EC44F8Q41092982-9AFBA210-4F4C-4335-9D14-17563F175075Q52568671-CB21DB69-B95C-47D4-9348-76398AA0E11F
P2860
Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@ast
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@en
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@nl
type
label
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@ast
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@en
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@nl
prefLabel
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@ast
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@en
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Peretinoin, an acyclic retinoi ...... y of hepatocellular carcinoma.
@en
P2093
Akito Sakai
Eishiro Mizukoshi
Kuniaki Arai
Masao Honda
Mikiko Nakamura
Shuichi Kaneko
Taro Yamashita
Tatsuya Yamashita
Yoshio Sakai
P2860
P2888
P356
10.1186/1471-2407-13-191
P407
P577
2013-04-15T00:00:00Z
P5875
P6179
1048418660